The REVEAL-1 study explores whether duodenal mucosal resurfacing, a minimally invasive endoscopic procedure, could help patients maintain their weight loss after they stop taking GLP-1s
They are glucagon-like peptide agonists, or GLP-1s, though technically I should be calling them GLP-1As
Safety studies on epigallocatechin gallate (EGCG) preparations
Additionally, symptoms of hypothyroidism (like fatigue and constipation) can overlap with the side effects of GLP-1 RAs, making it difficult to distinguish between the two if thyroid function is not first optimized
In the meantime, she had missed so many doses that she had to start back with the lowest possible dosage, delaying her progress
FDA approves Lillys Zepbound (tirzepatide) for chronic weight management, a powerful new option for the treatment of obesity or overweight with weight-related medical problems